Vice President Corp Strategy and Operations, F-star Therapeutics
Mark has a degree in Biochemistry from Oxford University, a PhD in Immunology and Molecular Biology from Imperial College and an MBA also from Oxford. He has worked in a range of business consulting roles and biotech companies, including a UCL spin out where he led three preclinical programmes towards the clinic. He has experience in advanced therapies (gene therapy), small molecules and biologics across a range of rare diseases as well as a more recent focus in immune-oncology. He joined F-star from Immunocore where he supported the CEO and leadership team in strategy and project management.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557